Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 30, 2025 Filed Feb 1, 2025 00:16 UTC |
Morrell MarthaCHIEF MEDICAL OFFICER
|
SaleCommon Stock | 200 | $15.00 | $3,000.00 |
DisclosureSEC source: 0001415889-25-002590 · form4-02012025_120253.xml · nonDerivative · entry 2 Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,762 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 00:16 UTC |
Morrell MarthaCHIEF MEDICAL OFFICER
|
SaleCommon Stock | 100 | $15.00 | $1,500.00 |
DisclosureSEC source: 0001415889-25-002590 · form4-02012025_120253.xml · nonDerivative · entry 1 Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,962 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 24, 2025 Filed Jan 28, 2025 23:08 UTC |
Morrell MarthaCHIEF MEDICAL OFFICER
|
SaleCommon Stock | 3,200 | $15.01 | $48,032.00 |
DisclosureSEC source: 0001415889-25-002207 · form4-01282025_110150.xml · nonDerivative · entry 1 Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 87,062 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.04, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form Read SEC document |
| January 22, 2025 Filed Feb 25, 2025 23:31 UTC |
Morrell MarthaCHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 265 | $14.04 | $3,720.60 |
DisclosureSEC source: 0001415889-25-005571 · form4-02252025_110243.xml · nonDerivative · entry 24 Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,075 Read SEC document |
| January 22, 2025 Filed Feb 25, 2025 17:41 UTC |
Kuhn RebeccaChief Financial Officer
|
Tax withholdingCommon Stock | 265 | $14.04 | $3,720.60 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 24 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,129 Read SEC document |
| January 06, 2025 Filed Jan 8, 2025 21:57 UTC |
Huennekens R ScottDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,507 | $0.00 Strike: $11.93 | $0.00 |
DisclosureSEC source: 0001415889-25-001147 · form4-01082025_090108.xml · derivative · entry 1 Huennekens R Scott · CIK 0001365493 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,507 Underlying: Common Stock · 15,507 shares Expires 2035-01-05 F1 · derivative.exercise_date: The shares subject to the option shall vest in thirty six (36) equal consecutive monthly installments until all of the option shares are fully vested and exercisable. Read SEC document |
| December 21, 2024 Filed Jun 24, 2025 20:30 UTC |
Geiger UriDirector
|
GrantCommon Stock | 1,029 | $11.53 | $11,864.37 |
DisclosureSEC source: 0001415889-25-018091 · form4-06242025_040607.xml · nonDerivative · entry 7 Geiger Uri · CIK 0001467361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,909 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| December 21, 2024 Filed Jun 24, 2025 20:30 UTC |
Fischer Frank MDirector
|
GrantCommon Stock | 2,059 | $11.53 | $23,740.27 |
DisclosureSEC source: 0001415889-25-018088 · form4-06242025_040601.xml · nonDerivative · entry 7 Fischer Frank M · CIK 0001297260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 585,275 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| December 21, 2024 Filed Jun 24, 2025 20:30 UTC |
LACOB JOSEPHDirector
|
GrantCommon Stock | 975 | $11.53 | $11,241.75 |
DisclosureSEC source: 0001415889-25-018090 · form4-06242025_040605.xml · nonDerivative · entry 7 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,065 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| December 21, 2024 Filed Jun 24, 2025 20:30 UTC |
Kumar RakhiDirector
|
GrantCommon Stock | 1,300 | $11.53 | $14,989.00 |
DisclosureSEC source: 0001415889-25-018089 · form4-06242025_040603.xml · nonDerivative · entry 7 Kumar Rakhi · CIK 0001856296 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,907 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| December 03, 2024 Filed Feb 25, 2025 23:31 UTC |
Morrell MarthaCHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 1,413 | $11.93 | $16,857.09 |
DisclosureSEC source: 0001415889-25-005571 · form4-02252025_110243.xml · nonDerivative · entry 23 Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,340 Read SEC document |
| December 03, 2024 Filed Feb 25, 2025 17:41 UTC |
Kuhn RebeccaChief Financial Officer
|
Tax withholdingCommon Stock | 1,334 | $11.93 | $15,914.62 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 23 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,394 Read SEC document |
| November 20, 2024 Filed Feb 25, 2025 23:31 UTC |
Morrell MarthaCHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 3,045 | $9.19 | $27,983.55 |
DisclosureSEC source: 0001415889-25-005571 · form4-02252025_110243.xml · nonDerivative · entry 22 Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,753 Read SEC document |
| November 20, 2024 Filed Feb 25, 2025 17:41 UTC |
Kuhn RebeccaChief Financial Officer
|
Tax withholdingCommon Stock | 3,045 | $9.19 | $27,983.55 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 22 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,728 Read SEC document |
| October 25, 2024 Filed Oct 28, 2024 19:49 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 223,991 | $5.45 | $1,221,042.14 |
DisclosureSEC source: 0001657662-24-000007 · primary_doc.xml · nonDerivative · entry 2 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,270,845 Read SEC document |
| October 23, 2024 Filed Oct 28, 2024 19:49 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 147 | $6.02 | $884.94 |
DisclosureSEC source: 0001657662-24-000007 · primary_doc.xml · nonDerivative · entry 1 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,494,836 Read SEC document |
| October 22, 2024 Filed Oct 24, 2024 18:23 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 4,082 | $6.09 | $24,853.26 |
DisclosureSEC source: 0001657662-24-000006 · primary_doc.xml · nonDerivative · entry 1 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,494,983 Read SEC document |
| October 22, 2024 Filed Feb 25, 2025 23:31 UTC |
Morrell MarthaCHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 237 | $6.00 | $1,422.00 |
DisclosureSEC source: 0001415889-25-005571 · form4-02252025_110243.xml · nonDerivative · entry 21 Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,798 Read SEC document |
| October 22, 2024 Filed Feb 25, 2025 17:41 UTC |
Kuhn RebeccaChief Financial Officer
|
Tax withholdingCommon Stock | 237 | $6.00 | $1,422.00 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 21 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,773 Read SEC document |
| October 21, 2024 Filed Oct 22, 2024 14:35 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 3,720 | $6.10 | $22,678.61 |
DisclosureSEC source: 0001657662-24-000005 · primary_doc.xml · nonDerivative · entry 2 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,499,065 Read SEC document |
| October 18, 2024 Filed Oct 22, 2024 14:35 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 4,878 | $6.29 | $30,691.89 |
DisclosureSEC source: 0001657662-24-000005 · primary_doc.xml · nonDerivative · entry 1 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,502,785 Read SEC document |
| October 17, 2024 Filed Oct 18, 2024 14:17 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 3,294 | $6.28 | $20,686.32 |
DisclosureSEC source: 0001657662-24-000004 · primary_doc.xml · nonDerivative · entry 11 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,507,663 Read SEC document |
| October 16, 2024 Filed Oct 18, 2024 14:17 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 6,900 | $6.57 | $45,336.45 |
DisclosureSEC source: 0001657662-24-000004 · primary_doc.xml · nonDerivative · entry 10 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,510,957 Read SEC document |
| October 15, 2024 Filed Oct 18, 2024 14:17 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 4,017 | $6.50 | $26,098.45 |
DisclosureSEC source: 0001657662-24-000004 · primary_doc.xml · nonDerivative · entry 9 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,517,857 Read SEC document |
| October 14, 2024 Filed Oct 18, 2024 14:17 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 4,031 | $6.54 | $26,359.92 |
DisclosureSEC source: 0001657662-24-000004 · primary_doc.xml · nonDerivative · entry 8 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,521,874 Read SEC document |
| October 11, 2024 Filed Oct 18, 2024 14:17 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 2,572 | $6.35 | $16,319.60 |
DisclosureSEC source: 0001657662-24-000004 · primary_doc.xml · nonDerivative · entry 7 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,525,905 Read SEC document |
| October 10, 2024 Filed Oct 18, 2024 14:17 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 2,504 | $6.12 | $15,316.97 |
DisclosureSEC source: 0001657662-24-000004 · primary_doc.xml · nonDerivative · entry 6 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,528,477 Read SEC document |
| October 09, 2024 Filed Oct 18, 2024 14:17 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 3,123 | $6.10 | $19,065.29 |
DisclosureSEC source: 0001657662-24-000004 · primary_doc.xml · nonDerivative · entry 5 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,530,981 Read SEC document |
| October 08, 2024 Filed Oct 18, 2024 14:17 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 6,000 | $6.43 | $38,551.80 |
DisclosureSEC source: 0001657662-24-000004 · primary_doc.xml · nonDerivative · entry 4 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,534,104 Read SEC document |
| October 07, 2024 Filed Oct 18, 2024 14:17 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 4,910 | $6.66 | $32,687.34 |
DisclosureSEC source: 0001657662-24-000004 · primary_doc.xml · nonDerivative · entry 3 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,540,104 Read SEC document |
| October 04, 2024 Filed Oct 18, 2024 14:17 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 5,757 | $6.92 | $39,829.80 |
DisclosureSEC source: 0001657662-24-000004 · primary_doc.xml · nonDerivative · entry 2 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,545,014 Read SEC document |
| October 03, 2024 Filed Oct 18, 2024 14:17 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 3,318 | $6.97 | $23,114.85 |
DisclosureSEC source: 0001657662-24-000004 · primary_doc.xml · nonDerivative · entry 1 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,550,771 Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 20:15 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 3,843 | $6.87 | $26,401.41 |
DisclosureSEC source: 0001062993-24-017384 · form4.xml · nonDerivative · entry 13 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,554,089 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:15 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 4,882 | $6.77 | $33,051.14 |
DisclosureSEC source: 0001062993-24-017384 · form4.xml · nonDerivative · entry 12 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,557,932 Read SEC document |
| September 30, 2024 Filed Oct 3, 2024 20:15 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 4,749 | $6.73 | $31,960.77 |
DisclosureSEC source: 0001062993-24-017384 · form4.xml · nonDerivative · entry 11 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,562,814 Read SEC document |
| September 30, 2024 Filed Jun 24, 2025 20:30 UTC |
Geiger UriDirector
|
GrantCommon Stock | 1,703 | $6.97 | $11,869.91 |
DisclosureSEC source: 0001415889-25-018091 · form4-06242025_040607.xml · nonDerivative · entry 6 Geiger Uri · CIK 0001467361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,880 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| September 30, 2024 Filed Jun 24, 2025 20:30 UTC |
Fischer Frank MDirector
|
GrantCommon Stock | 3,407 | $6.97 | $23,746.79 |
DisclosureSEC source: 0001415889-25-018088 · form4-06242025_040601.xml · nonDerivative · entry 6 Fischer Frank M · CIK 0001297260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 583,216 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| September 30, 2024 Filed Jun 24, 2025 20:30 UTC |
LACOB JOSEPHDirector
|
GrantCommon Stock | 1,614 | $6.97 | $11,249.58 |
DisclosureSEC source: 0001415889-25-018090 · form4-06242025_040605.xml · nonDerivative · entry 6 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,090 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| September 30, 2024 Filed Jun 24, 2025 20:30 UTC |
Kumar RakhiDirector
|
GrantCommon Stock | 2,152 | $6.97 | $14,999.44 |
DisclosureSEC source: 0001415889-25-018089 · form4-06242025_040603.xml · nonDerivative · entry 6 Kumar Rakhi · CIK 0001856296 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,607 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| September 27, 2024 Filed Oct 3, 2024 20:15 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 5,059 | $6.63 | $33,541.17 |
DisclosureSEC source: 0001062993-24-017384 · form4.xml · nonDerivative · entry 10 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,567,563 Read SEC document |
| September 26, 2024 Filed Oct 3, 2024 20:15 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 5,821 | $6.62 | $38,535.02 |
DisclosureSEC source: 0001062993-24-017384 · form4.xml · nonDerivative · entry 9 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,572,622 Read SEC document |
| September 25, 2024 Filed Oct 3, 2024 20:15 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 5,858 | $6.60 | $38,662.80 |
DisclosureSEC source: 0001062993-24-017384 · form4.xml · nonDerivative · entry 8 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,578,443 Read SEC document |
| September 23, 2024 Filed Oct 3, 2024 20:15 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 282 | $7.54 | $2,126.28 |
DisclosureSEC source: 0001062993-24-017384 · form4.xml · nonDerivative · entry 7 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,584,301 Read SEC document |
| September 20, 2024 Filed Oct 3, 2024 20:15 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 765 | $7.50 | $5,737.50 |
DisclosureSEC source: 0001062993-24-017384 · form4.xml · nonDerivative · entry 6 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,584,583 Read SEC document |
| September 13, 2024 Filed Oct 3, 2024 20:15 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 1,993 | $7.59 | $15,126.87 |
DisclosureSEC source: 0001062993-24-017384 · form4.xml · nonDerivative · entry 5 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,585,348 Read SEC document |
| September 06, 2024 Filed Oct 3, 2024 20:15 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 11 | $7.50 | $82.50 |
DisclosureSEC source: 0001062993-24-017384 · form4.xml · nonDerivative · entry 4 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,587,341 Read SEC document |
| September 04, 2024 Filed Oct 3, 2024 20:15 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 14 | $7.50 | $105.00 |
DisclosureSEC source: 0001062993-24-017384 · form4.xml · nonDerivative · entry 3 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,587,352 Read SEC document |
| September 03, 2024 Filed Oct 3, 2024 20:15 UTC |
KCK LTD.10% owner
|
SaleCommon Stock | 2,093 | $7.60 | $15,906.80 |
DisclosureSEC source: 0001062993-24-017384 · form4.xml · nonDerivative · entry 2 KCK LTD. · CIK 0001657662 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,587,366 Read SEC document |
| September 03, 2024 Filed Feb 25, 2025 23:31 UTC |
Morrell MarthaCHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 1,334 | $7.39 | $9,858.26 |
DisclosureSEC source: 0001415889-25-005571 · form4-02252025_110243.xml · nonDerivative · entry 20 Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,035 Read SEC document |
| September 03, 2024 Filed Feb 25, 2025 17:41 UTC |
Kuhn RebeccaChief Financial Officer
|
Tax withholdingCommon Stock | 1,334 | $7.39 | $9,858.26 |
DisclosureSEC source: 0001415889-25-005559 · form4-02252025_100218.xml · nonDerivative · entry 20 Kuhn Rebecca · CIK 0001855659 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,010 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.